GX Acquisition Corp.
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $287.50M |
|---|---|
| IPO Date | May 21, 2019 |
| CEO | Jay R. Bloom; Dean C. Kehler |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24+2 |
| IPO Sector | General ▶ |
| IPO Geography | Global |
| Target Company | Celularity |
| Deal Announced | Jan 8, 2021 |
| Deal Size, $M | $1,668.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jul 14, 2021 |
| Amendment Vote | TBD |
| Closing Date | Jul 16, 2021 |
Formerly GXGX
CELU
CELUW
| Price | $2.00 $0.20 |
|---|---|
| Last closing price | $1.97 |
| H/L, today | $1.91 / $2.01 |
| H/L, 52-week | $0.19 / $2.45 |
| Volume, today | 50,278 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.